Fakultní nemocnice Olomouc - Onkologická klinika

Olomouc, Olomouc Region 779 00

1 studies enrolling now · 2 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, MTAP-deleted Solid Tumors

Studies at this site

• A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors — Recruiting now
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling